FDA approves Imkeldi, imatinib as oral liquid, for certain leukemias
The oral liquid can treat specific forms of acute lymphoblastic leukemia and chronic myeloid leukemia, and other cancers, including rare ones.| Rare Cancer News
The experimental oral therapy VQ-101 can successfully restore a critical cellular function in people with a genetic form of Parkinson’s disease, the treatment’s developer, Vanqua Bio, has announced. One month […] The post VQ-101 restores enzyme lacking in GBA-linked Parkinson’s: Early trial appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News
The oral liquid can treat specific forms of acute lymphoblastic leukemia and chronic myeloid leukemia, and other cancers, including rare ones.| Rare Cancer News
